Cargando…

Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery

BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, N., Statkevicius, S., Asgeirsson, B., Schött, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589068/
https://www.ncbi.nlm.nih.gov/pubmed/26425342
http://dx.doi.org/10.1186/s13741-015-0019-7
_version_ 1782392738699804672
author Li, N.
Statkevicius, S.
Asgeirsson, B.
Schött, U.
author_facet Li, N.
Statkevicius, S.
Asgeirsson, B.
Schött, U.
author_sort Li, N.
collection PubMed
description BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure—not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the “Lund concept” of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy. METHODS: Thirty-nine patients undergoing elective brain tumour surgery with craniotomy received either 130/0.42 hydroxyethyl starch or 5 % albumin infusions. The first 18 patients received starch, whereas the rest received albumin. Rotational thromboelastometry with ROTEM and platelet aggregometry with Multiplate were performed before surgery, after the first and second consecutive colloid infusions (250/500 ml albumin or 500/1000 ml starch) and at the end of surgery. RESULTS: Both intra- and inter-group comparisons showed more deranged ROTEM parameters after the higher doses of starch. Multiplate detected changes only in the albumin group after 500-ml infusion. Blood los did not differ between groups, nor did haemoglobin preoperatively or at end of surgery. Lower volumes of albumin were required to maintain stable intra-operative haemodynamic parameters; 250/500 ml albumin corresponded to 500/1000 ml starch. CONCLUSIONS: Hydroxyethyl starch affected coagulation at lower volumes, with a more prominent effect on clot structure at the end of surgery, corroborating previous research. Only albumin decreased platelet aggregation, and 5 % albumin had a more potential volume effect than 130/0.42 hydroxyethyl starch.
format Online
Article
Text
id pubmed-4589068
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45890682015-10-01 Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery Li, N. Statkevicius, S. Asgeirsson, B. Schött, U. Perioper Med (Lond) Research BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure—not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the “Lund concept” of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy. METHODS: Thirty-nine patients undergoing elective brain tumour surgery with craniotomy received either 130/0.42 hydroxyethyl starch or 5 % albumin infusions. The first 18 patients received starch, whereas the rest received albumin. Rotational thromboelastometry with ROTEM and platelet aggregometry with Multiplate were performed before surgery, after the first and second consecutive colloid infusions (250/500 ml albumin or 500/1000 ml starch) and at the end of surgery. RESULTS: Both intra- and inter-group comparisons showed more deranged ROTEM parameters after the higher doses of starch. Multiplate detected changes only in the albumin group after 500-ml infusion. Blood los did not differ between groups, nor did haemoglobin preoperatively or at end of surgery. Lower volumes of albumin were required to maintain stable intra-operative haemodynamic parameters; 250/500 ml albumin corresponded to 500/1000 ml starch. CONCLUSIONS: Hydroxyethyl starch affected coagulation at lower volumes, with a more prominent effect on clot structure at the end of surgery, corroborating previous research. Only albumin decreased platelet aggregation, and 5 % albumin had a more potential volume effect than 130/0.42 hydroxyethyl starch. BioMed Central 2015-09-29 /pmc/articles/PMC4589068/ /pubmed/26425342 http://dx.doi.org/10.1186/s13741-015-0019-7 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, N.
Statkevicius, S.
Asgeirsson, B.
Schött, U.
Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title_full Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title_fullStr Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title_full_unstemmed Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title_short Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
title_sort effects of different colloid infusions on rotem and multiplate during elective brain tumour neurosurgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589068/
https://www.ncbi.nlm.nih.gov/pubmed/26425342
http://dx.doi.org/10.1186/s13741-015-0019-7
work_keys_str_mv AT lin effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery
AT statkeviciuss effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery
AT asgeirssonb effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery
AT schottu effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery